GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+12.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$383M
AUM Growth
+$31.4M
Cap. Flow
+$15.6M
Cap. Flow %
4.07%
Top 10 Hldgs %
62.79%
Holding
52
New
12
Increased
8
Reduced
12
Closed
10

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$44.1M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$19.1M
3
ARGX icon
argenx
ARGX
$14.2M
4
AXSM icon
Axsome Therapeutics
AXSM
$13.9M
5
BPMC
Blueprint Medicines
BPMC
$12.7M

Top Sells

1
IOVA icon
Iovance Biotherapeutics
IOVA
$24.5M
2
ASND icon
Ascendis Pharma
ASND
$18.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
$14.7M
4
TVTX icon
Travere Therapeutics
TVTX
$11.3M
5
ANAB icon
AnaptysBio
ANAB
$8.4M

Sector Composition

1 Healthcare 91.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BHVN
26
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.38M 0.91%
+100,000
New +$4.38M
KDMN
27
DELISTED
Kadmon Holdings, Inc.
KDMN
$4.33M 0.9%
2,100,000
– –
CHRS icon
28
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$3.87M 0.8%
175,000
-275,000
-61% -$6.08M
DRNA
29
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.7M 0.77%
+235,000
New +$3.7M
IOVA icon
30
Iovance Biotherapeutics
IOVA
$800M
$3.68M 0.76%
150,000
-1,000,000
-87% -$24.5M
ORTX
31
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.4M 0.71%
24,295
-5,705
-19% -$798K
CHMA
32
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2.99M 0.62%
400,000
-300,000
-43% -$2.24M
QURE icon
33
uniQure
QURE
$954M
$2.74M 0.57%
+35,000
New +$2.74M
QTTB icon
34
Q32 Bio
QTTB
$20.9M
$2.45M 0.51%
+6,944
New +$2.45M
PTGX icon
35
Protagonist Therapeutics
PTGX
$3.62B
$2.42M 0.5%
200,000
-500,000
-71% -$6.06M
ODT
36
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2.39M 0.49%
+65,000
New +$2.39M
ARQL
37
DELISTED
Arqule Inc
ARQL
$2.2M 0.46%
+200,000
New +$2.2M
SLDB icon
38
Solid Biosciences
SLDB
$448M
$575K 0.12%
6,667
– –
ALLK
39
DELISTED
Allakos
ALLK
$455K 0.09%
+10,500
New +$455K
GYRE icon
40
Gyre Therapeutics
GYRE
$734M
– –
-13,333
Closed -$811K
ANAB icon
41
AnaptysBio
ANAB
$630M
– –
-115,000
Closed -$8.4M
DBVT
42
DBV Technologies
DBVT
$249M
– –
-85,000
Closed -$6.55M
FGEN icon
43
FibroGen
FGEN
$48.4M
– –
-460
Closed -$625K
PFE icon
44
Pfizer
PFE
$141B
– –
0
– –
QQQ icon
45
Invesco QQQ Trust
QQQ
$364B
– –
0
– –
TVTX icon
46
Travere Therapeutics
TVTX
$1.75B
– –
-500,000
Closed -$11.3M
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$102B
– –
-80,000
Closed -$14.7M
XBI icon
48
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
-200,000
Closed -$2.56M
TCDA
50
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-150,000
Closed -$5.79M
1
2
3